文献速递妇产影像技术与安全US

双中心研究:超声影像组学能否区分CA125水平正常的I型和II型上皮性卵巢癌患者

A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?
PubMed 文献 · Br J Radiol · 2024-01-01

该双中心研究纳入58例CA125水平正常的上皮性卵巢癌患者,基于超声影像组学提取1130个特征构建联合模型并绘制列线图,联合模型在训练组和测试组的AUC分别为0.93和0.83,表明超声影像组学可区分CA125正常的I型和II型上皮性卵巢癌。

要点

  • CA125正常的上皮性卵巢癌患者约占该病人群的20%,需更精细的影像组学模型辅助分型。
  • 基于超声影像组学的联合模型在训练组和测试组的AUC分别为0.93和0.83。
  • Rad-score模型与临床模型AUC相近,分别为0.82和0.80。

核心结论

  • 超声影像组学可区分CA125水平正常的上皮性卵巢癌I型和II型。
  • 本研究首次聚焦CA125水平正常的上皮性卵巢癌病例,该亚组占该病人群的20%,可能需要更精细的影像组学模型。

研究设计与样本

  • 双中心研究,纳入58例经术前超声和病理证实的CA125水平正常的上皮性卵巢癌患者。
  • 从每例患者最典型的超声图像中基于肿瘤感兴趣区提取1130个影像组学特征。
  • 采用LASSO和逻辑回归分别筛选影像组学特征和临床特征,构建Rad-score模型和临床模型,并基于联合模型开发列线图。

诊断标准与关键数值

  • 联合模型在训练组和测试组的AUC分别为0.93和0.83。
  • Rad-score模型与临床模型的AUC相近,分别为0.82和0.80。
  • 校准曲线分析确定列线图在训练队列中与实际观察结果相符。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: CA125 is recommended by many countries as the primary screening test for ovarian cancer. But there are patients with ovarian cancer having normal CA125. We hope to identify the types of EOC with normal CA125 levels better by building a refined model based on the ultrasound radiomics, thus providing precise medical treatment for patients.

METHODS: We included 58 patients with EOC with normal CA125 from 2 centres, who were confirmed by preoperative ultrasound and pathology. We extracted 1130 radiomics features based on the tumour's region of interest from the most typical ultrasound image of each patient. We selected radiomics and clinical features by LASSO and logistic regression to construct Rad-score and clinical models, respectively. Receiver operating characteristic curves judged their test efficacy. On the basis of the combined model, we developed a nomogram.

RESULTS: Area under the curves (AUCs) of 0.93 and 0.83 were achieved in both the training and test groups for the combined model. There were similar AUCs between the Rad-score and clinical models of 0.82 and 0.80, respectively. By analysing the calibration curves, it was determined that the nomogram matched actual observations in the training cohort.

CONCLUSION: Ultrasound radiomics can differentiate type I and type II EOC with normal CA125 levels.

ADVANCES IN KNOWLEDGE: This study is the first to focus on EOC cases with normal level of CA125. The subset of patients constituting 20% of the disease population may require more refined radiomics models.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen L, Jin C, Chen B, et al. A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels? Br J Radiol. 2024. PMID: 39177575. doi:10.1093/bjr/tqae144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。